Humabiologics, Inc.
PrivateLast Round
Grant
Jan 8, 2025
Total Funding Raised
$1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Humabiologics, Inc. operates in Healthcare & Life Sciences and is based in Phoenix, Arizona. Its latest recorded funding round was a Grant round in January 2025.
Humabiologics, Inc. is a biotechnology company that develops and commercializes human-derived biomaterials, such as collagen and gelatin, for regenerative medicine therapies and research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Humabiologics, Inc. Comparables
Compare Humabiologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Obatala Sciences | 84% | |
| Jellagen | 82% | |
| Tessella Biosciences | 80% |
For institutional investors. Book with your work email.
Humabiologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2025 | ||||
| Seed | Jun 5, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Humabiologics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RegenMed Engine | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 55% MoM, from 2.6K to 4K.
- Jan 7, 2026
Monthly visitors increased 87% MoM.
For institutional investors. Book with your work email.
Humabiologics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Humabiologics, Inc.'s valuation, stock price, and market status.
Is Humabiologics, Inc. a public or private company?
Humabiologics, Inc. is a private company.
What is the current stock price of Humabiologics, Inc.?
Humabiologics, Inc. is a private company, so its shares have no public market price. Caplight tracks Humabiologics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Humabiologics, Inc. worth (valuation)?
Valuation information for Humabiologics, Inc. is not publicly available.
Can I buy Humabiologics, Inc. stock?
Humabiologics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Humabiologics, Inc.'s last funding round?
Humabiologics, Inc.'s most recent funding round was Grant on January 8, 2025.
Who are the main investors in Humabiologics, Inc.?
Key investors in Humabiologics, Inc. include RegenMed Engine, National Science Foundation.
Will Humabiologics, Inc. IPO soon?
No public IPO plans have been announced for Humabiologics, Inc..
How can I track Humabiologics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Humabiologics, Inc.'s shares on secondary markets.